Search for: "ACTAVIS"
Results 561 - 580
of 1,006
Sorted by Relevance
|
Sort by Date
19 Sep 2008, 6:54 am
Tom Hinchliffe was next to speak and did so on the recent case of Actavis v Merck which dealt with the question of whether the Court of Appeal could decide against its previous judgement in BMS v Baker Norton by which it should be bound. [read post]
14 Mar 2011, 5:35 am
Actavis v. [read post]
1 May 2010, 9:45 am
Generic manufacturers of metoclopramide including Teva Pharmaceuticals and Actavis Elizabeth. [read post]
2 Apr 2007, 9:52 pm
Actavis Norvasc: Pfizer v. [read post]
17 Jun 2008, 10:48 pm
June 17, 2008) (here's a link), Gladys Mensing sued both the pioneer and generic manufacturers of Reglan, prescribed to treat her diabetic gastroparesis, when she developed tardive dyskinesia.Two generic manufacturers, Actavis and Pliva, moved for summary judgment on the ground of preemption. [read post]
8 May 2008, 6:20 pm
On April 28, 2008, the corporation responsible for this dangerous heart drug, Actavis Totowa, LLC, announced along with FDA officials this nationwide Type I Drug Recall after tablets were found to have double the thickness in size. [read post]
31 Mar 2009, 12:16 pm
" Almost a year ago, in late April 2008, all digoxin pills manufactured by Actavis Totowa -- marketed under the Digitek brand name -- were recalled due to this so-called "double-dose" manufacturing problem. [read post]
5 Mar 2015, 4:00 am
Supreme Court's lead in Actavis, albeit in a split decision. [read post]
5 Aug 2008, 1:40 am
Supreme Court rules in religious-based discrimination case - The blogging constitutionalists at the American Constitution Society at their ACS Blog Update on pharmaceutical giant Actavis Totowa LLC - Bryan Lester at Heygood, Orr, Bartolomei, Reyes & Bartolomei at the firm's Angel Reyes Blog Does the manager of an LLC have a fiduciary duty to the members of the LLC? [read post]
23 Feb 2010, 5:05 am
Cross-checking his conclusion using the European Patent Office's problem-solution approach discussed by Lord Justice Jacob in his recent judgment in Actavis v Novartis (noted here by the IPKat, in what is this weblog's all-time most commented-upon post), Arnold J concluded that the skilled team of researchers could have solved the problem before them without needing to look beyond the relevant prior art, so obviousness was proved.This judgment is far too long for the IPKat to… [read post]
20 Oct 2008, 10:59 am
Patients are still reeling from the Digitek recall in April and the mounting reports of deaths and serious injuries associated with Actavis Totowa’s negligence in that case. [read post]
7 Jan 2018, 12:47 pm
Actavis regarding the infringement by equivalent means of Eli Lilly’s patent EP 1 313 508 (not only because the Supreme Court remanded the case back to the Federal Patent Court and we can therefore expect a new decision in this matter in 2018). [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
26 Apr 2018, 4:48 am
However he did not agree with Arnold J that it is necessary to determine whether the product embodies the inventive advance of the patent, which is referred to in the CJEU’s decision in Actavis v Sanofi (C-443/12), noting that the Actavis case was only concerned with Article 3(c), not 3(a) and commenting that he had difficulty in understanding the difference between the “core inventive advance” and the invention disclosed by the claims. [read post]
6 Jan 2010, 3:32 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Wellbutrin (Bupropion) – US: An employee benefit plan files motion to certify class action against Biovail and GlaxoSmithKline alleging companies conspired to delay generic Wellbutrin by filing baseless patent suits (GenericsWeb) Emend (Fosaprepitant dimeglumine) – US: FDA issues exclusivity decision for Merck’s… [read post]
4 May 2011, 4:13 am
(Docket Report) Provigil (Modafinil) – EU announces anti-trust probe into a Cephalon – Teva deal concerning generic Provigil (The IP Factor) (GenericsWeb) Valsartan – Norway: District Court of Oslo forbids Actavis to market any products containing Valsartan produced by using the process QSSA Route C until 13 May 2011 (EPLAW) Welchol (Colesevelam) – US: Daiichi Sankyo, Genzyme file patent infringement complaint against Watson in response to Para IV certification… [read post]
25 Mar 2020, 9:58 am
Actavis, 570 U.S. 136 (2013) (finding that so-called “reverse” settlement agreements between pharmaceutical manufacturers may be subject to antitrust scrutiny when certain conditions are satisfied); (2) even if such settlements are subject to antitrust scrutiny, it is improper to apply an “inherently suspect” or “quick look” competitive analysis, rather than a full rule-of-reason analysis to assess anticompetitive effects; and (3) the Commissioners failed… [read post]
22 Apr 2013, 2:43 pm
Actavis – $202 million Actavis Group Hf, one of the world’s largest pharmaceutical manufacturers and distributors, agreed to pay $202.6 million to settle allegations in numerous False Claims Act lawsuits that the company reported inflated prices of its drugs, causing the US and four state governments to overpay. [read post]
25 Mar 2020, 9:58 am
Actavis, 570 U.S. 136 (2013) (finding that so-called “reverse” settlement agreements between pharmaceutical manufacturers may be subject to antitrust scrutiny when certain conditions are satisfied); (2) even if such settlements are subject to antitrust scrutiny, it is improper to apply an “inherently suspect” or “quick look” competitive analysis, rather than a full rule-of-reason analysis to assess anticompetitive effects; and (3) the Commissioners failed… [read post]
23 Dec 2010, 10:02 am
Mensing (09-993), Actavis v. [read post]
